Nerandomilast in Patients with Progressive Pulmonary Fibrosis

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2503643
Affiliations:
22
Authors:
20
Institutions Authors Share
Boehringer Ingelheim International GmbH, Germany
4.000000
0.20
Boehringer Ingelheim Pharmaceuticals, Inc., United States of America (USA)
2.000000
0.10
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)
1.000000
0.05
Hospital Universitario de La Princesa, Spain
1.000000
0.05
Boehringer Ingelheim - Netherlands, Netherlands
1.000000
0.05
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
1.000000
0.05
University of Michigan (U-M), United States of America (USA)
1.000000
0.05
UMass Memorial Health, United States of America (USA)
1.000000
0.05
Erasmus University Medical Center (Erasmus MC), Netherlands
1.000000
0.05
Agostino Gemelli University Polyclinic, Italy
1.000000
0.05
Boehringer Ingelheim - Belgium, Belgium
1.000000
0.05
Hôpital Louis Pradel, France
0.500000
0.03
Infections Virales et Pathologie Comparée (IVPC), France
0.500000
0.03
Imperial College London (ICL), United Kingdom (UK)
0.500000
0.03
Nippon Medical School, Japan
0.500000
0.03
Tokorozawa Mihara General Hospital, Japan
0.500000
0.03
Marienhaus Klinikum Mainz, Germany
0.500000
0.03
Oslo University Hospital (OUS), Norway
0.500000
0.03
University Hospital Zurich (UHZ), Switzerland
0.500000
0.03
University of Southern California (USC), United States of America (USA)
0.500000
0.03
University Medical Center Mainz, JGU, Germany
0.500000
0.03